Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andri Rauch

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
The Journal of Infectious Diseases|March 20, 2020
Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort StudyBernard Surial, Bruno Ledergerber, Alexandra Calmy, et al.
Plos One|October 3, 2014
Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivoMohamed Abdel-Mohsen, Xutao Deng, Ali Danesh, et al.
HIV Medicine|February 25, 2025
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfectionCharles Béguelin, Bernard Surial, Eveline Hofmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2023
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort StudyLukas Baumann, Dominique L Braun, Matthias Cavassini, et al.
Annals of Internal Medicine|March 15, 2021
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort StudyBernard Surial, Catrina Mugglin, Alexandra Calmy, et al.
Plos One|July 16, 2015
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected PatientsDominique L Braun, Andri Rauch, Manel Aouri, et al.
Antiviral Therapy|June 21, 2011
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNASara Gianella, Viktor von Wyl, Marek Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyBernard Surial, Frédérique Chammartin, José Damas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2024
Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral TherapyTeja Turk, Marco Labarile, Dominique L Braun, et al.
The Journal of Infectious Diseases|November 21, 2022
Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 ComparedKalongo Hamusonde, Dunja Nicca, Huldrych F Gnthard, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
The Journal of Infectious Diseases|March 20, 2020
Changes in Renal Function After Switching From TDF to TAF in HIV-Infected Individuals: A Prospective Cohort StudyBernard Surial, Bruno Ledergerber, Alexandra Calmy, et al.
Plos One|October 3, 2014
Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivoMohamed Abdel-Mohsen, Xutao Deng, Ali Danesh, et al.
HIV Medicine|February 25, 2025
Frequent hepatitis B surface antigen (HBsAg) clearance during tenofovir therapy in persons with HIV/hepatitis B virus coinfectionCharles Béguelin, Bernard Surial, Eveline Hofmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 18, 2023
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort StudyLukas Baumann, Dominique L Braun, Matthias Cavassini, et al.
Annals of Internal Medicine|March 15, 2021
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV : A Cohort StudyBernard Surial, Catrina Mugglin, Alexandra Calmy, et al.
Plos One|July 16, 2015
A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected PatientsDominique L Braun, Andri Rauch, Manel Aouri, et al.
Antiviral Therapy|June 21, 2011
Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNASara Gianella, Viktor von Wyl, Marek Fischer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 9, 2023
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyBernard Surial, Frédérique Chammartin, José Damas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 1, 2024
Characterization and Determinants of Long-Term Immune Recovery Under Suppressive Antiretroviral TherapyTeja Turk, Marco Labarile, Dominique L Braun, et al.
The Journal of Infectious Diseases|November 21, 2022
Triggers of Change in Sexual Behavior Among People With HIV: The Swiss U U Statement and COVID-19 ComparedKalongo Hamusonde, Dunja Nicca, Huldrych F Gnthard, et al.
Pageof 23